News

Following the approval from the FDA, Aeterna Zentaris expects to initiate a Phase 2 clinical trial in this indication in the second half of this year. The study

As per the agreement, Abbott is expected to gain rights to at least 24 Zydus products in 15 key emerging markets where Abbott has a growing presence. The

Novus Biologicals said that this new kit allows researchers to use any antibody, regardless of the buffer or concentration, with Lightning Link Kits. Antibodies are sometimes only available

Sanofi-aventis said that the rationale of the trial was based on post-hoc findings from the Athena trial, in which a trend towards reduction of CV hospitalisation and death

PLx Pharma claimed that the other grants NIH has awarded to it in the recent months include The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

According to the Alnylam, the new study performed in collaboration with scientists at the Max Planck Institute of Molecular Cell Biology and Genetics and AlCana Technologies, described a

The Phase 2 trial enrolled 140 patients who have been randomised to either orBec or placebo at a 2:1 ratio. The primary endpoint of this trial is the

Derma Sciences has hired Maeve Kelly as managing director for EMEA (Europe, Middle East, Africa regions). Ms Kelly will report directly to Barry Wolfenson, executive vice president of

For the first quarter of 2010, Ranbaxy Laboratories has posted a EBITDA of $298m, compared to a loss of $201m for the prior year period. Profit after tax